[
    [
        {
            "time": "2023-10-30",
            "orginal_text": "北上资金本月抢筹股名单",
            "features": {
                "keywords": [
                    "北上资金",
                    "抢筹",
                    "名单"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "original_text": "北上资金本月抢筹股名单",
            "scores": {
                "News_content": "北上资金本月抢筹股名单",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "复星医药副总裁彭奕然辞职 董监高成员变化",
            "features": {
                "keywords": [
                    "复星医药",
                    "副总裁",
                    "辞职",
                    "董监高"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "复星医药副总裁彭奕然辞职 董监高成员变化",
            "scores": {
                "News_content": "复星医药副总裁彭奕然辞职 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "复星医药、天士力、华北制药总裁、总经理、董事长辞职 董监高成员变化",
            "features": {
                "keywords": [
                    "复星医药",
                    "天士力",
                    "华北制药",
                    "辞职",
                    "董监高"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "复星医药、天士力、华北制药总裁、总经理、董事长辞职 董监高成员变化",
            "scores": {
                "News_content": "复星医药、天士力、华北制药总裁、总经理、董事长辞职 董监高成员变化",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "复星医药关于高级管理人员辞职的公告 董监高成员变化",
            "features": {
                "keywords": [
                    "复星医药",
                    "高级管理人员",
                    "辞职",
                    "公告"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "复星医药关于高级管理人员辞职的公告 董监高成员变化",
            "scores": {
                "News_content": "复星医药关于高级管理人员辞职的公告 董监高成员变化",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "28股主力资金净流入超亿元",
            "features": {
                "keywords": [
                    "主力资金",
                    "净流入",
                    "亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "original_text": "28股主力资金净流入超亿元",
            "scores": {
                "News_content": "28股主力资金净流入超亿元",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "复星医药：复宏汉霖拟为汉霖制药1.5亿元的银行借款提供担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "担保",
                    "借贷"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "复星医药：复宏汉霖拟为汉霖制药1.5亿元的银行借款提供担保 大额借贷担保",
            "scores": {
                "News_content": "复星医药：复宏汉霖拟为汉霖制药1.5亿元的银行借款提供担保 大额借贷担保",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "复星医药：增长态势延续 全面恢复",
            "features": {
                "keywords": [
                    "复星医药",
                    "增长",
                    "全面恢复"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药：增长态势延续 全面恢复",
            "scores": {
                "News_content": "复星医药：增长态势延续 全面恢复",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "艾德证券期货：恒指连日下跌后将进入触底休整 科技公司或将高位盘整",
            "features": {
                "keywords": [
                    "恒指",
                    "下跌",
                    "触底",
                    "科技公司",
                    "盘整"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "艾德证券期货：恒指连日下跌后将进入触底休整 科技公司或将高位盘整",
            "scores": {
                "News_content": "艾德证券期货：恒指连日下跌后将进入触底休整 科技公司或将高位盘整",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "复星医药三季报点评：业绩符合预期，创新药物成功出海!",
            "features": {
                "keywords": [
                    "复星医药",
                    "三季报",
                    "业绩",
                    "创新药物",
                    "出海"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药三季报点评：业绩符合预期，创新药物成功出海!",
            "scores": {
                "News_content": "复星医药三季报点评：业绩符合预期，创新药物成功出海!",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-30",
            "orginal_text": "礼来4.4亿美元引进复星医药BCL-2抑制剂",
            "features": {
                "keywords": [
                    "礼来",
                    "复星医药",
                    "BCL-2抑制剂",
                    "引进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "礼来4.4亿美元引进复星医药BCL-2抑制剂",
            "scores": {
                "News_content": "礼来4.4亿美元引进复星医药BCL-2抑制剂",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]